{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:29:24Z","timestamp":1790922564843,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T00:00:00Z","timestamp":1609286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Is angiogenic potential of follicular fluid (FF) and granulosa-lutein cells (GLCs) altered in polycystic ovary syndrome (PCOS) and does it play a role in corpus luteum (CL) defect observed in them?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>FF and GLCs of women with PCOS show reduced expression of pro-angiogenic factors compared to controls and exhibit a diminished capacity to induce angiogenesis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>In women with PCOS, CL insufficiency and frequent miscarriage are reported, which may be due to defect in CL. The development of new blood vessels is essential to promote ovarian folliculogenesis and functional CL formation. The vasculature formation in CL which is important for its function is still unexplored in these women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>This case-control study was conducted in 30 healthy control women and 30 women with PCOS undergoing controlled ovarian hyperstimulation for IVF. The FF, GLCs and serum were collected from all participants during ovum pick up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>The capacity of FF to induce angiogenesis was assessed by measuring levels of pro-angiogenic factors vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2) and its tube formation and wound healing potential using human umbilical vein endothelial cells (HUVECs). We investigated the angiogenic potential and endothelial cell-like nature of GLCs using several approaches such as the expression of angiogenic genes by quantitative PCR, DiI-conjugated acetylated low-density lipoproteins (Dil-Ac-LDL) internalization assay, tube formation assay, expression of endothelial cell markers by immunofluorescence analysis. In addition, correlation of transcript levels of angiogenic genes with oocyte parameters was studied.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>FF and serum levels of VEGF and FGF2 were significantly higher and lower, respectively, in PCOS compared to controls. The tube formation and wound healing capacity of HUVECs was found to be reduced when measured after supplementation with FF of women with PCOS compared to controls. This suggests a decreased angiogenic capacity of FF in women with PCOS. Tube formation (P\u2009=\u20090.003) and Dil-Ac-LDL internalization (P\u2009=\u20090.03) ability of GLCs were significantly reduced in women with PCOS compared to controls. Protein expression levels of endothelial markers, vascular endothelial growth factor A (VEGFA) (P\u2009=\u20090.004), vascular endothelial growth factor receptor 2 (VEGFR2) (P\u2009=\u20090.011), TEK Receptor Tyrosine Kinase (Tie-2) (P\u2009=\u20090.026), fibroblast growth factor receptor 1 (FGFR1) (P\u2009=\u20090.026) and CD31 (P\u2009=\u20090.035) and transcript levels of angiogenic genes VEGFA (P\u2009=\u20090.042), hypoxia inducing factor 1A (HIF1A) (P\u2009=\u20090.025), FGF2 (P\u2009=\u20090.038), angiopoietin 1 (ANGPT1) (P\u2009=\u20090.028), heparin sulfate proteoglycan 2 (HSPG2) (P\u2009=\u20090.016), ADAM metallopeptidase with thrombospondin type1 motif, 1 (ADAMTS1) (P\u2009=\u20090.027) and fibronectin 1 (FN1) (P\u2009=\u20090.016) were found to be low in GLCs of PCOS compared to controls. Thus, the findings of this study indicate that endothelial cell-like characteristics of GLCs were significantly decreased in PCOS. Furthermore, transcript levels of VEGFA (r\u2009=\u20090.46, P\u2009=\u20090.009), ADAMTS1 (r\u2009=\u20090.55, P\u2009=\u20090.001), FGF2 (r\u2009=\u20090.42, P\u2009=\u20090.022) and ANGPT2 (r\u2009=\u20090.47, P\u2009=\u20090.008) showed a positive correlation with oocyte fertilization rate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The vasculature formation in CL is not possible to study in women, but we explored the angiogenic characteristics of FF and GLC obtained from women with PCOS to speculate any vascularization defect of CL in these women. The FF and GLCs were obtained from the stimulated cycle during oocyte retrieval, which may not exactly mimic the in-vivo condition. The small sample size is another limitation of this study. Larger sample size and support by color Doppler studies on CL blood flow would help to strengthen our findings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>Our findings suggest that the altered angiogenic potential of FF and GLCs may affect vasculature development required for CL formation and function in PCOS. These findings pave the way to devise therapeutic strategies to support angiogenesis process in follicle of women with PCOS, which may improve CL insufficiency, progesterone levels and prevent frequent miscarriages in these women. Furthermore, our study also hypothesizes that the vascularization around the ovarian follicles is also compromised which may lead to the growth arrest of the follicles in PCOS, however, this needs thorough investigations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>This work was supported by Grant BT\/PR16524\/MED\/97\/346\/2016 from the Department of Biotechnology, Government of India. The authors have no conflicts of interest to disclose.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deaa351","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T22:01:19Z","timestamp":1606946479000},"page":"1052-1064","source":"Crossref","is-referenced-by-count":43,"title":["Alteration in angiogenic potential of granulosa-lutein cells and follicular fluid contributes to luteal defects in polycystic ovary syndrome"],"prefix":"10.1093","volume":"36","author":[{"given":"Krutika","family":"Patil","sequence":"first","affiliation":[{"name":"Department of Molecular Endocrinology, ICMR-National Institute for Research in Reproductive Health, Parel, Mumbai 400012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Hinduja","sequence":"additional","affiliation":[{"name":"Hinduja IVF Centre, P.D. Hinduja National Hospital and Medical Research Centre, Mumbai 400016, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srabani","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, ICMR-National Institute for Research in Reproductive Health, Parel, Mumbai 400012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,30]]},"reference":[{"key":"2021032420083180300_deaa351-B1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejogrb.2004.07.024","article-title":"Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow","volume":"118","author":"Abd El Aal","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2021032420083180300_deaa351-B2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humrep\/13.3.651","article-title":"Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries","volume":"13","author":"Agrawal","year":"1998","journal-title":"Hum Reprod"},{"key":"2021032420083180300_deaa351-B3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/biolre\/ioz114","article-title":"Prokineticin 1 is a new biomarker of human oocyte competence: expression and hormonal regulation throughout late folliculogenesis","volume":"101","author":"Alfaidy","year":"2019","journal-title":"Biol Reprod"},{"key":"2021032420083180300_deaa351-B4","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1210\/jc.2014-2086","article-title":"Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development","volume":"100","author":"Ambekar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2021032420083180300_deaa351-B5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jprot.2013.05.017","article-title":"Proteomic analysis of human follicular fluid: a new perspective towards understanding folliculogenesis","volume":"87","author":"Ambekar","year":"2013","journal-title":"J Proteomics"},{"key":"2021032420083180300_deaa351-B6","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/humrep\/15.11.2306","article-title":"The vascular character of ovarian follicular granulosa cells: phenotypic and functional evidence for an endothelial-like cell population","volume":"15","author":"Antczak","year":"2000","journal-title":"Hum Reprod"},{"key":"2021032420083180300_deaa351-B7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/09513590600906607","article-title":"Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation","volume":"22","author":"Artini","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"2021032420083180300_deaa351-B8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/14647270802621358","article-title":"Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF","volume":"12","author":"Artini","year":"2009","journal-title":"Hum Fertil (Camb)"},{"key":"2021032420083180300_deaa351-B9","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1038\/s41598-020-60935-1","article-title":"HIF1 driven transcriptional activity regulates steroidogenesis and proliferation of bovine granulosa cells","volume":"10","author":"Baddela","year":"2020","journal-title":"Sci Rep"},{"key":"2021032420083180300_deaa351-B10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1177\/002215549804600908","article-title":"Secreted protein, acidic and rich in cysteine (SPARC) and thrombospondin in the developing follicle and corpus luteum of the rat","volume":"46","author":"Bagavandoss","year":"1998","journal-title":"J Histochem Cytochem"},{"key":"2021032420083180300_deaa351-B11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygcen.2009.12.013","article-title":"Expression and localization of stanniocalcin 1 in swine ovary","volume":"166","author":"Basini","year":"2010","journal-title":"Gen Comp Endocrinol"},{"key":"2021032420083180300_deaa351-B12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/ahe.12180","article-title":"Angiogenesis in the ovary\u2014the most important regulatory event for follicle and corpus luteum development and function in cow\u2014an overview","volume":"45","author":"Berisha","year":"2016","journal-title":"Anat Histol Embryol"},{"key":"2021032420083180300_deaa351-B13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12079-009-0060-8","article-title":"Thrombospondins function as regulators of angiogenesis","volume":"3","author":"Bornstein","year":"2009","journal-title":"J Cell Commun Signal"},{"key":"2021032420083180300_deaa351-B14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12020-012-9778-9","article-title":"Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact on fertility","volume":"43","author":"Boutzios","year":"2013","journal-title":"Endocrine"},{"key":"2021032420083180300_deaa351-B15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1095\/biolreprod.110.084434","article-title":"ADAMTS1 cleavage of versican mediates essential structural remodeling of the ovarian follicle and cumulus-oocyte matrix during ovulation in mice","volume":"83","author":"Brown","year":"2010","journal-title":"Biol Reprod"},{"key":"2021032420083180300_deaa351-B16","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/0002-9378(88)90256-6","article-title":"Angiogenic, mitogenic, and chemotactic activity of human follicular fluid","volume":"158","author":"Bryant","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"2021032420083180300_deaa351-B17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"2021032420083180300_deaa351-B18","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0002-9440(10)64322-2","article-title":"Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries","volume":"162","author":"Ferrara","year":"2003","journal-title":"Am J Pathol"},{"key":"2021032420083180300_deaa351-B19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1126\/science.6200930","article-title":"Initiation of angiogenesis by human follicular fluid","volume":"224","author":"Frederick","year":"1984","journal-title":"Science"},{"key":"2021032420083180300_deaa351-B20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00404-018-4967-2","article-title":"Abnormal expressions of ADAMTS-1, ADAMTS-9 and progesterone receptors are associated with lower oocyte maturation in women with polycystic ovary syndrome","volume":"299","author":"GohariTaban","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"2021032420083180300_deaa351-B56614227","first-page":"124","volume":"50","author":"Hammadeh","year":"2003"},{"key":"2021032420083180300_deaa351-B21","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/humrep\/des325","article-title":"Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome","volume":"27","author":"Haouzi","year":"2012","journal-title":"Hum Reprod"},{"key":"2021032420083180300_deaa351-B22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/beog.2000.0133","article-title":"Angiogenesis in ovarian follicular and luteal development","volume":"14","author":"Hazzard","year":"2000","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"key":"2021032420083180300_deaa351-B922","first-page":"351","volume":"27","year":"1976"},{"key":"2021032420083180300_deaa351-B23","first-page":"157","article-title":"Expression of vascular permeability factor\/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development","volume":"146","author":"Kamat","year":"1995","journal-title":"Am J Pathol"},{"key":"2021032420083180300_deaa351-B24","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2021032420083180300_deaa351-B25","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2021032420083180300_deaa351-B26","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.3390\/ijms19113500","article-title":"Endogenous ovarian angiogenesis in polycystic ovary syndrome-like rats induced by low-frequency electro-acupuncture: the CLARITY three-dimensional approach","volume":"19","author":"Ma","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2021032420083180300_deaa351-B27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10815-019-01659-8","article-title":"ADAMTS1 and HSPG2 mRNA levels in cumulus cells are related to human oocyte quality and controlled ovarian hyperstimulation outcomes","volume":"37","author":"Ma","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"2021032420083180300_deaa351-B28","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1095\/biolreprod.102.013714","article-title":"Expression of messenger RNA for ADAMTS subtypes changes in the periovulatory follicle after the gonadotropin surge and during luteal development and regression in cattle","volume":"69","author":"Madan","year":"2003","journal-title":"Biol Reprod"},{"key":"2021032420083180300_deaa351-B29","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1590\/S0100-879X2004001100007","article-title":"Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome","volume":"37","author":"Meenakumari","year":"2004","journal-title":"Braz J Med Biol Res"},{"key":"2021032420083180300_deaa351-B30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.anireprosci.2017.02.006","article-title":"Fibroblast growth factor 2 (FGF2) and vascular endothelial growth factor A (VEGFA) synergistically promote steroidogenesis and survival of cultured buffalo granulosa cells","volume":"179","author":"Mishra","year":"2017","journal-title":"Anim Reprod Sci"},{"key":"2021032420083180300_deaa351-B31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yjmcc.2013.07.006","article-title":"PKC\u03b5 activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting","volume":"63","author":"Monti","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"2021032420083180300_deaa351-B32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1530\/EJE-08-0932","article-title":"Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome","volume":"160","author":"Mukherjee","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2021032420083180300_deaa351-B33","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1093\/humrep\/dei068","article-title":"Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF","volume":"20","author":"Onalan","year":"2005","journal-title":"Hum Reprod"},{"key":"2021032420083180300_deaa351-B34","doi-asserted-by":"crossref","first-page":"e0214742","DOI":"10.1371\/journal.pone.0214742","article-title":"Quantitative mass spectrometric analysis to unravel glycoproteomic signature of follicular fluid in women with polycystic ovary syndrome","volume":"14","author":"Patil","year":"2019","journal-title":"PLoS One"},{"key":"2021032420083180300_deaa351-B35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/cvr\/cvq045","article-title":"Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling","volume":"86","author":"Rey","year":"2010","journal-title":"Cardiovasc Res"},{"key":"2021032420083180300_deaa351-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/ENDO:12:1:1","article-title":"Angiogenesis in the corpus luteum","volume":"12","author":"Reynolds","year":"2000","journal-title":"Endocrine"},{"key":"2021032420083180300_deaa351-B37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum Reprod"},{"key":"2021032420083180300_deaa351-B38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/bmj.297.6655.1027","article-title":"Recurrent early miscarriage and polycystic ovaries","volume":"297","author":"Sagle","year":"1988","journal-title":"BMJ"},{"key":"2021032420083180300_deaa351-B39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/molehr\/gat051","article-title":"Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women","volume":"20","author":"Schmidt","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"2021032420083180300_deaa351-B40","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mrd.22343","article-title":"Platelet-derived growth factor BB and DD and angiopoietin1 are altered in follicular fluid from polycystic ovary syndrome patients","volume":"81","author":"Scotti","year":"2014","journal-title":"Mol Reprod Dev"},{"key":"2021032420083180300_deaa351-B41","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.fertnstert.2010.03.049","article-title":"Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome","volume":"94","author":"Sova","year":"2010","journal-title":"Fertil Steril"},{"key":"2021032420083180300_deaa351-B42","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1210\/jc.2005-0643","article-title":"Angiogenesis in the human corpus luteum: changes in expression of angiopoietins in the corpus luteum throughout the menstrual cycle and in early pregnancy","volume":"90","author":"Sugino","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2021032420083180300_deaa351-B43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0035-1552582","article-title":"The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome","volume":"33","author":"Tal","year":"2015","journal-title":"Semin Reprod Med"},{"key":"2021032420083180300_deaa351-B44","first-page":"1942","article-title":"Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism","volume":"6","author":"Tilly","year":"1992","journal-title":"Mol Endocrinol"},{"key":"2021032420083180300_deaa351-B45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/molehr\/gan040","article-title":"HCG up-regulates hypoxia inducible factor-1 alpha in luteinized granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum","volume":"14","author":"van den Driesche","year":"2008","journal-title":"Mol Hum Reprod"},{"key":"2021032420083180300_deaa351-B46","first-page":"443","article-title":"Heparan sulfate in angiogenesis: a target for therapy","volume":"17","author":"van Wijk","year":"2014","journal-title":"Angiogenesis"},{"key":"2021032420083180300_deaa351-B48","doi-asserted-by":"crossref","first-page":"E1015","DOI":"10.1210\/jc.2013-4177","article-title":"Evidence for decreased expression of ADAMTS-1 associated with impaired oocyte quality in PCOS patients","volume":"99","author":"Xiao","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2021032420083180300_deaa351-B49","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/mrd.20878","article-title":"Effect of local neutralization of basic fibroblast growth factor or vascular endothelial growth factor by a specific antibody on the development of the corpus luteum in the cow","volume":"75","author":"Yamashita","year":"2008","journal-title":"Mol Reprod Dev"},{"key":"2021032420083180300_deaa351-B50","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/molehr\/gah079","article-title":"ADAMTS-1\/METH-1 and TIMP-3 expression in the primate corpus luteum: divergent patterns and stage-dependent regulation during the natural menstrual cycle","volume":"10","author":"Young","year":"2004","journal-title":"Mol Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/36\/4\/1052\/36713024\/deaa351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/36\/4\/1052\/36713024\/deaa351.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T20:09:02Z","timestamp":1616616542000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/36\/4\/1052\/6055412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,30]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12,30]]},"published-print":{"date-parts":[[2021,3,18]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaa351","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,12,30]]}}}